Siemens Healthineers AG (SMMNY)
21.64
+0.12
(+0.54%)
USD |
OTCM |
Oct 08, 16:00
Siemens Healthineers Gross Profit Margin (Quarterly) : 42.51% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.51% |
| March 31, 2026 | 37.68% |
| December 31, 2025 | 38.43% |
| September 30, 2025 | 37.55% |
| June 30, 2025 | 38.52% |
| March 31, 2025 | 39.31% |
| December 31, 2024 | 39.26% |
| September 30, 2024 | 38.05% |
| June 30, 2024 | 38.54% |
| March 31, 2024 | 36.91% |
| December 31, 2023 | 37.96% |
| September 30, 2023 | 37.86% |
| June 30, 2023 | 37.22% |
| March 31, 2023 | 30.36% |
| December 31, 2022 | 36.58% |
| September 30, 2022 | 38.70% |
| June 30, 2022 | 36.04% |
| March 31, 2022 | 37.34% |
| December 31, 2021 | 37.63% |
| September 30, 2021 | 37.94% |
| Date | Value |
|---|---|
| June 30, 2021 | 38.42% |
| March 31, 2021 | 37.98% |
| December 31, 2020 | 40.49% |
| September 30, 2020 | 37.10% |
| June 30, 2020 | 38.47% |
| March 31, 2020 | 40.71% |
| December 31, 2019 | 38.14% |
| September 30, 2019 | 39.72% |
| June 30, 2019 | 38.58% |
| March 31, 2019 | 41.10% |
| December 31, 2018 | 40.38% |
| September 30, 2018 | 41.01% |
| June 30, 2018 | 38.67% |
| March 31, 2018 | 41.66% |
| December 31, 2017 | 41.53% |
| September 30, 2017 | 42.62% |
| June 30, 2017 | 40.94% |
| March 31, 2017 | 40.90% |
| December 31, 2016 | 42.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Inspecs Group Plc | -- |
| SheerVision, Inc. | -- |
| Carl Zeiss Meditec AG | -- |
| Organogenesis Holdings, Inc. | 30.84% |
| Drägerwerk AG & Co. KGaA | 46.64% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.25% |
| Return on Assets | 5.02% |
| Return on Invested Capital | 6.71% |
| Profit Margin (Quarterly) | 11.73% |
| Operating Margin (Quarterly) | 17.73% |
| Return on Net Operating Assets | 5.71% |